BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10171477)

  • 21. Fighting graft--it's academic. Medical centers must embrace conflict rules: critics.
    Romano M
    Mod Healthc; 2006 Jan; 36(5):8-10. PubMed ID: 16479773
    [No Abstract]   [Full Text] [Related]  

  • 22. Commercial support of continuing medical education in the United States: the politics of doubt, the value of studies.
    Mazmanian PE
    J Contin Educ Health Prof; 2009; 29(2):81-3. PubMed ID: 19530200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
    Chen P;
    Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
    [No Abstract]   [Full Text] [Related]  

  • 24. Physician preferences and attitudes regarding industry support of CME programs.
    Mueller PS; Hook CC; Litin SC
    Am J Med; 2007 Mar; 120(3):281-5. PubMed ID: 17349454
    [No Abstract]   [Full Text] [Related]  

  • 25. Adapting to decreased industry support of CME: lifelong education in an "industry-lite" world.
    Yager J; Silverman JJ; Rapaport MH
    Acad Psychiatry; 2011; 35(2):101-5. PubMed ID: 21403160
    [No Abstract]   [Full Text] [Related]  

  • 26. The AVF, FDA, AMA, AAMC, ACCME, and CME.
    Johnson G
    J Vasc Surg; 1993 Nov; 18(5):731-3. PubMed ID: 8230556
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmaceutical industry financial support for medical education: benefit, or undue influence?
    Brody H
    J Law Med Ethics; 2009; 37(3):451-60, 396. PubMed ID: 19723256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical education and communication companies: an updated in-depth profile.
    Golden GA; Parochka JN; Overstreet KM
    J Contin Educ Health Prof; 2002; 22(1):55-62. PubMed ID: 12004641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Concerning the pharmaceutical industry's financing of post-graduate courses].
    Costa Alcaraz AM; Pereiro Berenguer I; Suberviola Collados V
    Aten Primaria; 2001 Apr; 27(6):440-2. PubMed ID: 11334584
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines on gifts to physicians from industry: an update.
    American Medical Association. Council on Ethical and Judicial Affairs
    Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuing medical education--limiting industry's influence.
    Fonseca R
    N Engl J Med; 2010 Mar; 362(11):1053; author reply 1053-4. PubMed ID: 20301802
    [No Abstract]   [Full Text] [Related]  

  • 32. Industry support of medical education.
    Relman AS
    JAMA; 2008 Sep; 300(9):1071-3. PubMed ID: 18768419
    [No Abstract]   [Full Text] [Related]  

  • 33. The uncertain future of continuing medical education: commercialism and shifts in funding.
    Van Harrison R
    J Contin Educ Health Prof; 2003; 23(4):198-209. PubMed ID: 14730790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuing medical education--limiting industry's influence.
    Colburn L; Dorman T
    N Engl J Med; 2010 Mar; 362(11):1052; author reply 1053-4. PubMed ID: 20237356
    [No Abstract]   [Full Text] [Related]  

  • 35. Ties that bind? The web of CME and medical industry profit.
    Busby J
    Tex Med; 1991 Aug; 87(8):38-46. PubMed ID: 1925989
    [No Abstract]   [Full Text] [Related]  

  • 36. Examining the value of commercially supported CME.
    Miller LA
    J Contin Educ Health Prof; 2009; 29(1):68-70. PubMed ID: 19288557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing an instrument to measure bias in CME.
    Takhar J; Dixon D; Donahue J; Marlow B; Campbell C; Silver I; Eadie J; Monette C; Rohan I; Sriharan A; Raymond K; Macnab J
    J Contin Educ Health Prof; 2007; 27(2):118-23. PubMed ID: 17576631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
    Rutledge P; Crookes D; McKinstry B; Maxwell SR
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commercial funding of accredited continuing medical education.
    Tabas JA; Baron RB
    BMJ; 2012 Feb; 344():e810. PubMed ID: 22344304
    [No Abstract]   [Full Text] [Related]  

  • 40. What is the enemy in CME, conflicts of interest or bias?
    Lo B; Ott C
    JAMA; 2013 Sep; 310(10):1019-20. PubMed ID: 23959071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.